Log in to search using one of your social media accounts:

This page shows you the latest items in this publication.

A Medical Diagnosis Is Not an Immediate Product of a Process in the Meaning of § 9, Sentence 2, No. 3 PatG
Biotechnology Law Report Feb 2017, Vol. 36, No. 1: 23-23. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - January 31, 2017 Category: Medical Law Source Type: research

New Guidances from FDA for Biosimilars and Interchangeables
Biotechnology Law Report Feb 2017, Vol. 36, No. 1: 17-21. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - January 31, 2017 Category: Medical Law Source Type: research

AbbVie Hopes to Maintain Humira Exclusivity Through Secondary Patents and Regulatory Barriers to Entry
Biotechnology Law Report Feb 2017, Vol. 36, No. 1: 9-16. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - January 31, 2017 Category: Medical Law Source Type: research

Selected Developments in Biotechnology Law and the Biotechnology Industry
Biotechnology Law Report Feb 2017, Vol. 36, No. 1: 5-7. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - January 31, 2017 Category: Medical Law Source Type: research

The 2017 Update to the Coordinated Framework for the Regulation of Biotechnology
Biotechnology Law Report Feb 2017, Vol. 36, No. 1: 1-3. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - January 31, 2017 Category: Medical Law Source Type: research

Biotechnology Patenting in Small Countries —Strategies for the International Marketplace
Biotechnology Law Report Dec 2016, Vol. 35, No. 6: 291-299. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - November 30, 2016 Category: Medical Law Authors: Mindaugas Kiskis Tadas Limba Source Type: research

The Status Quo and Development Strategies for Patent Pledge Financing in the Biopharmaceutical Industry in China
Biotechnology Law Report Dec 2016, Vol. 35, No. 6: 285-290. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - November 30, 2016 Category: Medical Law Authors: Yunhua Liu Jing Li Source Type: research

Considerations Regarding Patent Assertion Entities in the Biotechnology Field: New FTC Study Released
Biotechnology Law Report Dec 2016, Vol. 35, No. 6: 281-284. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - November 30, 2016 Category: Medical Law Authors: Ricardo Unikel Source Type: research

The Biotechnology Regulatory Authority of India Bill, 2013 —A Threat to the Safety of India's Food and Farming
Biotechnology Law Report Dec 2016, Vol. 35, No. 6: 269-280. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - November 30, 2016 Category: Medical Law Authors: A. Saravanan Source Type: research

A Decade of Data Protection for Innovative Drugs in Canada: Issues, Limitations, and Time for a Reassessment
Biotechnology Law Report Dec 2016, Vol. 35, No. 6: 259-267. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - November 30, 2016 Category: Medical Law Authors: Megan Kendall Declan Hamill Source Type: research

Setbacks in Implementing the Renewable Fuel Standard Lead to Calls for Reform
Biotechnology Law Report Dec 2016, Vol. 35, No. 6: 249-257. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - November 30, 2016 Category: Medical Law Authors: Christopher M. Holman Source Type: research

Selected Developments in Biotechnology Law and the Biotechnology Industry
Biotechnology Law Report Dec 2016, Vol. 35, No. 6: 247-248. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - November 30, 2016 Category: Medical Law Authors: Steven J. Zweig Source Type: research

Post-Election Uncertainty and Opportunity Beckon
Biotechnology Law Report Dec 2016, Vol. 35, No. 6: 245-246. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - November 30, 2016 Category: Medical Law Authors: Lucian C. Chen Source Type: research

After Two Years, Alice Is Still Stifling Life Sciences Patents; But the Tide May Be Shifting at the Federal Circuit
Biotechnology Law Report Oct 2016, Vol. 35, No. 5: 239-244. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - September 30, 2016 Category: Medical Law Authors: Lucian C. Chen Source Type: research

The Status of Patent Eligibility in the Area of Biotechnology: Practical Considerations for Patent Prosecutors
Biotechnology Law Report Oct 2016, Vol. 35, No. 5: 225-238. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - September 30, 2016 Category: Medical Law Authors: Mike Sanzo Source Type: research

Biophysical Evidence Relevant to the Patentability of Engineered Antibodies: Using Computational Simulations to Assist the Objective Analysis Required by Section § 112(a)
Biotechnology Law Report Oct 2016, Vol. 35, No. 5: 187-223. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - September 30, 2016 Category: Medical Law Authors: Brian K. Lathrop Source Type: research

Mayo Update: Some Reason for Guarded Optimism
Biotechnology Law Report Oct 2016, Vol. 35, No. 5: 175-185. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - September 30, 2016 Category: Medical Law Authors: Christopher M. Holman Source Type: research

Selected Developments in Biotechnology Law and the Biotechnology Industry
Biotechnology Law Report Oct 2016, Vol. 35, No. 5: 171-173. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - September 30, 2016 Category: Medical Law Authors: Steven J. Zweig Source Type: research

Turbulent and Exciting Times at BLR
Biotechnology Law Report Oct 2016, Vol. 35, No. 5: 169-169. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - September 30, 2016 Category: Medical Law Authors: Lucian C. Chen Source Type: research

Patenting Genes in China, the U.S., and the EU: How Does It Differ? Could It Get Out of Control?
Biotechnology Law Report Aug 2016, Vol. 35, No. 4: 165-168. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - July 31, 2016 Category: Medical Law Authors: Wei Li Source Type: research

Patenting Decisions by South African Biotechnology Entrepreneurs
Biotechnology Law Report Aug 2016, Vol. 35, No. 4: 147-163. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - July 31, 2016 Category: Medical Law Authors: Donrich W. Jordaan Source Type: research

Succession in Title and Priority Entitlement in the European Patent Office
Biotechnology Law Report Aug 2016, Vol. 35, No. 4: 141-146. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - July 31, 2016 Category: Medical Law Authors: Steven M. Zeman Source Type: research

The Medicines Company v. Hospira: When Does Outsourcing Drug Manufacture to a Third-Party Contractor Trigger an On-Sale Bar to Patentability?
Biotechnology Law Report Aug 2016, Vol. 35, No. 4: 129-136. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - July 31, 2016 Category: Medical Law Authors: Christopher M. Holman Source Type: research

Selected Developments in Biotechnology Law and the Biotechnology Industry
Biotechnology Law Report Aug 2016, Vol. 35, No. 4: 125-127. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - July 31, 2016 Category: Medical Law Authors: Steven J. Zweig Source Type: research

Controversy and Guidance for Biosimilar Labeling
Biotechnology Law Report , Vol. 0, No. 0. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 22, 2016 Category: Medical Law Authors: Vishal GuptaRichard Praseuth Source Type: research

Supplementary Document 2: Affirmance of Refusal for Registration
Biotechnology Law Report Jun 2016, Vol. 35, No. 3: 119-124. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 19, 2016 Category: Medical Law Source Type: research

Supplementary Document 1: Request for Reconsideration of Denial of Copyright Registration of Prancer DNA Sequence
Biotechnology Law Report Jun 2016, Vol. 35, No. 3: 113-118. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 19, 2016 Category: Medical Law Source Type: research

Are Engineered Genetic Sequences Copyrightable?: The U.S. Copyright Office Addresses a Matter of First Impression
Biotechnology Law Report Jun 2016, Vol. 35, No. 3: 103-111. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 19, 2016 Category: Medical Law Authors: Christopher M. HolmanClaes GustafssonAndrew W. Torrance Source Type: research

Independent Consultant on Intellectual Property
Biotechnology Law Report Jun 2016, Vol. 35, No. 3: 99-102. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 19, 2016 Category: Medical Law Authors: Richard J. WarburgRobert Kelly MooreStephen B. Maebius Source Type: research

Prior Art Status of Drug Standard Evidence in China's Pharmaceutical Patent Invalidation Process
Biotechnology Law Report Jun 2016, Vol. 35, No. 3: 93-97. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 19, 2016 Category: Medical Law Authors: Yu JiFeixiang Guo Source Type: research

Genetic Technologies Ltd. v. Merial L.L.C.: Gene-Based Assays in the Wake of Mayo
Biotechnology Law Report Jun 2016, Vol. 35, No. 3: 89-92. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 19, 2016 Category: Medical Law Authors: Michael Sanzo Source Type: research

Two Recent U.S. Reports Identify Shortcomings in USDA's Regulation of GE Crops
Biotechnology Law Report Jun 2016, Vol. 35, No. 3: 83-88. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 19, 2016 Category: Medical Law Authors: Christopher M. Holman Source Type: research

Selected Developments in Biotechnology Law and the Biotechnology Industry
Biotechnology Law Report Jun 2016, Vol. 35, No. 3: 81-82. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 19, 2016 Category: Medical Law Authors: Steven J. Zweig Source Type: research

Selected Developments in Biotechnology Law and the Biotechnology Industry
Biotechnology Law Report Aug 2014, Vol. 33, No. 4: 133-134. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - August 14, 2014 Category: Medical Law Tags: article Source Type: research

Informed Consent and Ethical Review in Chinese Human Experimentation: Reflections on the “Golden Rice Event”
Biotechnology Law Report Aug 2014, Vol. 33, No. 4: 155-160. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - August 14, 2014 Category: Medical Law Tags: article Source Type: research

Q&A Session with Dr. Andrew W. Torrance of the University of Kansas School of Law: On the Question: Is Copyright the Way to Gain Intellectual Property Protection for DNA Sequences?
Biotechnology Law Report Aug 2014, Vol. 33, No. 4: 139-140. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - August 14, 2014 Category: Medical Law Tags: article Source Type: research

Caught Between a Rock and a Hard Place: How Limelight Compounds the Challenges Facing Biotechnology Innovators After Mayo and Myriad
Biotechnology Law Report Aug 2014, Vol. 33, No. 4: 135-138. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - August 14, 2014 Category: Medical Law Tags: article Source Type: research

Structure and Application of the Exception Principle to Drug Patent Experiments in China
Biotechnology Law Report Aug 2014, Vol. 33, No. 4: 141-144. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - August 14, 2014 Category: Medical Law Tags: article Source Type: research

Patenting Bio/Pharma Inventions: A Comparative View of the Patent Systems in the U.S. and China
Biotechnology Law Report Aug 2014, Vol. 33, No. 4: 145-153. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - August 14, 2014 Category: Medical Law Tags: article Source Type: research

Selected Developments in Biotechnology Law and the Biotechnology Industry
Biotechnology Law Report Jun 2014, Vol. 33, No. 3: 91-93. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 16, 2014 Category: Medical Law Tags: article Source Type: research

Legal Protection of China's Biotechnology Patents
Biotechnology Law Report Jun 2014, Vol. 33, No. 3: 103-107. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 16, 2014 Category: Medical Law Tags: article Source Type: research

PTO Subject Matter Eligibility Guidance: An Ill-Advised Overextension of Myriad
Biotechnology Law Report Jun 2014, Vol. 33, No. 3: 120-132. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 16, 2014 Category: Medical Law Tags: article Source Type: research

The Federal Circuit's Ongoing Expansion of Obviousness-Type Double Patenting Creates Patent Prosecution Pitfalls
Biotechnology Law Report Jun 2014, Vol. 33, No. 3: 94-97. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - June 16, 2014 Category: Medical Law Tags: article Source Type: research

Selected Developments in Biotechnology Law and the Biotechnology Industry
Biotechnology Law Report Apr 2014, Vol. 33, No. 2: 43-45. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - April 16, 2014 Category: Medical Law Tags: article Source Type: research

Q & A Session with Professor Benjamin Liu of the John Marshall Law School: On the Impact of Myriad, on Developments in Chinese Patent Law, and on Advice for Young Academics Looking to Enter the Business World
Biotechnology Law Report Apr 2014, Vol. 33, No. 2: 49-51. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - April 16, 2014 Category: Medical Law Tags: article Source Type: research

In AMP v. Myriad, the Supreme Court Provides an Analytical Framework for Patent Eligibility of Product Claims That Is Different from That for Method Claims
Biotechnology Law Report Apr 2014, Vol. 33, No. 2: 81-89. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - April 16, 2014 Category: Medical Law Tags: article Source Type: research

District Court's Interpretation of Mayo in Ariosa Diagnostics Does Not Bode Well for Patent Eligibility of Diagnostics and Personalized Medicine
Biotechnology Law Report Apr 2014, Vol. 33, No. 2: 46-48. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - April 16, 2014 Category: Medical Law Tags: article Source Type: research

Legal Protection of China's Biotechnology Patents*
Biotechnology Law Report , Vol. 0, No. 0. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - April 15, 2014 Category: Medical Law Tags: article Source Type: research

Filter and Barrier in Biotechnology Patent Applications in China
Biotechnology Law Report , Vol. 0, No. 0. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - April 14, 2014 Category: Medical Law Tags: article Source Type: research

Intellectual Property Rights and Pharmaceutical Trade Dress: Options for Protecting the Appearance of Prescription Drugs
Biotechnology Law Report , Vol. 0, No. 0. (Source: Biotechnology Law Report)
Source: Biotechnology Law Report - April 14, 2014 Category: Medical Law Tags: article Source Type: research